Supernus Pharmaceuticals (SUPN) Cash from Discontinued Operations (2011)
Supernus Pharmaceuticals (SUPN) posted quarterly Cash from Discontinued Operations of 120000.0 for Q4 2011, down 109.18% on a QoQ basis from 1307000.0 in Q3 2011.
Supernus Pharmaceuticals (SUPN) Cash from Discontinued Operations (2011) Analysis & Trends
Supernus Pharmaceuticals has reported Cash from Discontinued Operations for 1 years, with the latest figure at 120000.0 in Q4 2011.
- Cash from Discontinued Operations for Q4 2011 came in at 120000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2011 was 2021000.0 (changed N/A YoY), and the FY2011 annual result was 2021000.0, up 674.15% from the prior year.
- Cash from Discontinued Operations slipped to 120000.0 in Q4 2011, from 1307000.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 1749000.0 in Q1 2011 and troughed at 915000.0 in Q2 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.37 Bn | 185.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -120,000.00 |
| Dec 31, 2011 | -120,000.00 |
| Sep 30, 2011 | 1.31 Mn |
| Sep 30, 2011 | 1.31 Mn |
| Jun 30, 2011 | -915,000.00 |
| Jun 30, 2011 | -915,000.00 |
| Mar 31, 2011 | 1.75 Mn |
| Mar 31, 2011 | 1.75 Mn |